Anal canal cancer

TUESDAY, April 22 (HealthDay News) — According to a U.S. study if compared to the standard treatment process for anal canal cancer, use of cisplatin before other treatments didn’t provide diseases-free survival and caused an increased rate of artificial anus procedures.

Chemoradiation

Presently, the ideal primary therapy for patients with anal canal cancer is chemoradiation which achieves a five-year survival rate of about 65 percent, according to background information in the study.

Survival rate

The background information in the study shows that the available ideal basic treatment for patients with anal cancer is chemoradiation, which gets a five-year survival rate of almost 65 percent.